75
Participants
Start Date
November 30, 2010
Primary Completion Date
September 20, 2013
Study Completion Date
December 26, 2013
Romiplostim
Romiplostim will be administered weekly by subcutaneous injection
Research Site, Randwick
Research Site, Woolloongabba
Research Site, Adelaide
Research Site, A Coruña
Research Site, Philadelphia
Research Site, Bethesda
Research Site, Monza (MB)
Research Site, Dijon
Research Site, Richlands
Research Site, Novara
Research Site, Majadahonda
Research Site, Hickory
Research Site, Alcorcón
Research Site, Málaga
Research Site, Charleston
Research Site, Toulouse
Research Site, Boynton Beach
Research Site, Pessac
Research Site, Vicenza
Research Site, Düsseldorf
Research Site, Duisburg
Research Site, Cologne
Research Site, Bari
Research Site, San Giovanni Rotondo FG
Research Site, Napoli
Research Site, Anaheim
Research Site, Orange
Research Site, Bondy
Research Site, Créteil
Research Site, Catania
Research Site, Brno
Research Site, Ostrava-Poruba
Research Site, Prague
Research Site, Prague
Research Site, Prague
Research Site, Dresden
Research Site, Roma
Research Site, Gdansk
Research Site, Katowice
Research Site, Lublin
Research Site, Poznan
Research Site, Wroclaw
Research Site, Barcelona
Research Site, Coventry
Research Site, Leeds
Research Site, London
Research Site, London
Research Site, Oxford
Lead Sponsor
Amgen
INDUSTRY